CoChat

A factor analytic study in bipolar depression, and response to lamotrigine

Open access
Mitchell, Philip B., Hadzi-Pavlovic, Dusan, Evoniuk, Gary, Calabrese, Joseph R., Bowden, Charles L. · 2013 · CNS Spectrums

The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.

Abstract

Objective: There have been no previous factor analytic studies of the Hamilton Depression Rating Scale (HDRS) in samples with bipolar I depression, and no investigations of the utility of any derived factors in determining treatment response in this condition. This study aimed to identify and compare factors of a 31-item version of the HDRS (HDRS-31) in large samples of patients with bipolar depression and Major Depressive Disorder (MDD), then examine the responsiveness of such factors to lamotrigine compared with placebo in the bipolar depressed sample. Methods: This multivariate analytical study was performed on 2 large depressed samples (one bipolar and the other MDD) that had been recruited for separate, contemporaneous, double-blind placebo-controlled trials of lamotrigine. The 2 studies had similar designs and assessment tools, the major measures being the Montgomery–Asberg Depression Rating Scale (MADRS) and HDRS-31. To identify the constructs underlying the scale, exploratory factor analyses were conducted using HDRS-31 baseline scores. Treatment responsiveness in the bipolar depressed sample—as indicated by improvement in the total MADRS and HDRS-31, as well as HDRS factors—were examined using both a mixed-effects analysis and individual time-point t-tests. Results: Seven factors of the HDRS-31 were identified: I—“depressive cognitions,” II—“psychomotor retardation,” III—“insomnia,” IV—“hypersomnia,” V—“appetite and weight change,” VI—“anxiety,” and VII—“anergia.” A significant therapeutic effect of lamotrigine in bipolar depression was found for the “depressive cognitions” factor (from week 3) and “psychomotor retardation” (from week 4). Conclusion: This study has identified 7 factors of the HDRS in a large sample of patients with bipolar depression. The results suggest that that the clinical benefits of lamotrigine in acute bipolar depression are primarily upon depressive cognitions and psychomotor slowing.

Overview

Integrity signals

Registry

Crossref · 10.1017/s1092852913000291

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 3

  1. 2001, S-Plus 6 for Windows Guide to Statistics, Volume I
  2. Laurenza, 1999, A double-blind, placebo-controlled study supporting the efficacy of lamotrigine in unipolar depression, Bipolar Disord, 1, 39
  3. Muthen, 1998, Mplus User's Guide

Cited by

See all 20

Metadata

Authors
Mitchell, P. B., Hadzi-Pavlovic, D., Evoniuk, G., Calabrese, J. R., & Bowden, C. L.
Affiliations
  • Black Dog Institute (AU)
  • Case Western Reserve University (US)
  • The University of Texas at San Antonio Health Science Center (US)
Corresponding author
Mitchell, Philip B.
Venue
CNS Spectrums
Published
2013-05-23
Volume
18
Issue
4
Pages
214-224
ISSN
  • 1092-8529 (ISSN-L)
  • 2165-6509
OpenAlex
W2142310626
Cited by
20
References
36
Citations by year
2024: 2 · 2022: 1 · 2021: 3 · 2018: 3 · 2017: 1 · 2016: 4 · 2015: 2 · 2014: 2 · 2013: 1
FWCI
2.13
Type
journal article
Language
en
Open access
Locations
  • CNS Spectrums (publishedVersion)
  • PubMed (publishedVersion)
  • UNSWorks (UNSW Sydney) (submittedVersion, cc-by-nc-nd)
  • UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Mental Health Research Topics
Keywords
bipolar depression, lamotrigine, Hamilton Depression Rating Scale, factor structure, treatment response, depressive cognitions, psychomotor retardation, major depressive disorder, mood stabilizers
MeSH terms
Lamotrigine, Adult, Antidepressive Agents, Bipolar Disorder, Depressive Disorder, Double-Blind Method, Drug Administration Schedule, Factor Analysis, Statistical, Humans, Psychiatric Status Rating Scales, Triazines, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.